For full access for members, please log in - [ Member Login ]
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Comments and Press StatementsIMS comments on new study 'Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies'Press Statement – January 17, 2012 Hormone DHEA shows promise in helping women through menopause and towards a better sex lifePress Statement – December 20, 2011 IMS statement to support International Osteoporosis Foundation’s World Osteoporosis DayPress Statement – October 20, 2011 World Menopause Day press release – 'Menopausal Hot Flushes - new study shows women don't have to suffer, says International Menopause Society'Press Statement – October 18, 2011 Withdrawal of HRT implant may lead to problems for patientsPress Statement – July 15, 2011 Estrogen-only menopausal hormone therapy and the reduced incidence of breast cancerPress Statement – December 14, 2010 IMS press release on a critical window for hormone therapy and dementia riskPress Statement – November 22, 2010 Menopause clinicians support findings of new report on menopausal hormone therapyPress Statement – July 20, 2010 International Menopause Society comment on press release from the European Heart JournalComment – March 11, 2010 Menopause clinicians reply to Lancet paper on HRT and lung cancerPress Statement – September 20, 2009 NEJM Article on Breast Cancer and HRTComment – February 4, 2009 Comment on recent paper on risk of myocardial infarction and use of hormone therapyComment – October 12, 2008 Hormone therapy and postmenopausal BRCA1 mutation carriersPress Statement – September 23, 2008 WISDOM study: Re-confirming improved quality of life in all HRT usersPress Statement – August 22, 2008 The effects of tibolone in older postmenopausal womenPress statement on the new data on the LIFT Trial – August 14, 2008 Health risks after cessation of postmenopausal hormone therapyPress statement on the new data from the WHI Investigators Breast cancer and hormone therapy: a looking-glass mirror?Press statement on the new data from the Kaiser Permanente study The heart of the WHI study: time for hormone therapy policies to be revisedClimacteric 2007;10:267–269 Postmenopausal hormone therapy and coronary disease – the truth of the matterPress Statement – June 20, 2007 IMS launches a new campaign to improve assessment of cardiovascular risk by gynaecologists in menopausal womenPress Statement – June 14, 2007 IMS reaction to a special report on breast cancer incidence in 2003 in the United StatesPress Statement – April 19, 2007 Response to the Lancet paper on ovarian cancer in the Million Women StudyPress Statement – April 18, 2007 Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisitedPress Statement – April 3, 2007 Recommendations on postmenopausal hormone therapyPress Statement – February 27, 2007 Reaction to recent breast cancer data Press Statement – December 19, 2006 Response to recent publication: WHI and breast cancerPress Statement – April 11, 2006 Response to recent publications from WHI and Nurses’ Health StudyPress Statement – February 13, 2006 Presidential Comment on IARC Monographs Program on CarcinogenicityComment on Endometrial cancer in the Million Women StudyMay 12, 2005 Comment on the NIH press release concerning the estrogen-only study arm of the WHIMarch 4, 2004 Practical recommendations for hormone replacement therapy in the peri- and postmenopauseClimacteric 2004;7:210–16 Statement from the International Menopause SocietyIn reply to the decision by the EMEA not to recommend hormone replacement therapy for the indication for prevention of osteoporosis Time for new long-term trials of postmenopausal hormone therapies!Climacteric 2003;6:265–67 The Founding Members of the IMSClimacteric 2003;6:174 The end of WISDOMClimacteric 2002;5:313–16 Report on the 10th World Congress on the MenopauseClimacteric 2002;5:219–28 The View of the International Menopause Society on the Women's Health InitiativeClimacteric 2002;5:211–16 Executive summary: Stages of Reproductive Aging Workshop (STRAW)Climacteric 2001;4:267–72 |
 |
|
[home] - [site map] - [contact us]
International Menopause Society, Ms Lee Tomkins, IMS Executive Director, PO Box 98, Camborne, Cornwall TR14 4BQ, UK
Tel: +44 1209 711 054, Fax: +44 1209 610 530, E-mail: leetomkinsims@btinternet.com
